Literature DB >> 11752606

MAP kinases and the regulation of nuclear receptors.

J M Kyriakis1.   

Abstract

The activity of nuclear receptors or ligand-activated transcription factors can be regulated both positively and negatively by signals transduced through mitogen-activated protein kinase (MAPK) signaling cascades. Kyriakis discusses how cross talk between MAPK signaling and nuclear receptor signaling occurs and the effect this cross talk has on nuclear receptor function.

Mesh:

Substances:

Year:  2000        PMID: 11752606     DOI: 10.1126/stke.2000.48.pe1

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  6 in total

1.  Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.

Authors:  Elke Burgermeister; Dana Chuderland; Tamar Hanoch; Markus Meyer; Mordechai Liscovitch; Rony Seger
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

2.  Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.

Authors:  Sabyasachi Bhattacharya; Juan Qian; Christos Tzimas; Darren P Baker; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

3.  Mixed lineage kinase 3 requires a functional CRIB domain for regulation of blood pressure, cardiac hypertrophy, and left ventricular function.

Authors:  Pei-Wen Liu; Gregory L Martin; Weiyu Lin; Wanting Huang; Suchita Pande; Mark J Aronovitz; Roger J Davis; Robert M Blanton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-07-22       Impact factor: 5.125

4.  Site-specific phosphorylation induces functionally active conformation in the intrinsically disordered N-terminal activation function (AF1) domain of the glucocorticoid receptor.

Authors:  Anna M S Garza; Shagufta H Khan; Raj Kumar
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

5.  Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions.

Authors:  Anna S Garza; Aaron L Miller; Betty H Johnson; E Brad Thompson
Journal:  Leuk Res       Date:  2008-11-13       Impact factor: 3.156

6.  Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells.

Authors:  Aaron L Miller; Anna S Garza; Betty H Johnson; E Brad Thompson
Journal:  Cancer Cell Int       Date:  2007-03-28       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.